Greater Cannabis Company (GCAN) Enterprise Value (2017 - 2026)
Greater Cannabis Company's (GCAN) quarterly Enterprise Value came in at -$1439.0 in Q1 2026, up 96.89% year-on-year from -$730.88 in Q1 2025, and down 76.56% quarter-over-quarter from -$815.0 in Q4 2025.
Greater Cannabis Company (GCAN) Enterprise Value (2017 - 2026) Analysis & Trends
Greater Cannabis Company's Enterprise Value history runs 10 years deep, the most recent figure standing at -$1439.0 for Q1 2026.
- On a quarterly basis, Enterprise Value rose 96.89% year-over-year to -$1439.0 in Q1 2026; TTM through Mar 2026 was -$1439.0, a 96.89% increase from a year earlier, with the FY2025 full-year figure at -$815.0, up 98.58% from the prior year.
- Enterprise Value eased to -$1439.0 in Q1 2026 per GCAN's latest filing, from -$815.0 in the prior quarter.
- Across five years, Enterprise Value topped out at -$815.0 in Q4 2025 and bottomed at -$311197.0 in Q2 2022.
- The 5-year median for Enterprise Value is -$62282.0 (2024), against an average of -$108819.7.
- Across the five-year window, Enterprise Value advanced 22.64% in 2023 and jumped 98.58% in 2025, its largest moves.
- Year by year, Enterprise Value stood at -$270030.0 in 2022, then soared by 38.21% to -$166859.0 in 2023, then soared by 65.62% to -$57368.0 in 2024, then soared by 98.58% to -$815.0 in 2025, then sank by 76.56% to -$1439.0 in 2026.
- Per Business Quant, the three latest GCAN Enterprise Value figures stand at -$1439.0 (Q1 2026), -$815.0 (Q4 2025), and -$21355.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Greater Cannabis Company | 292,929.85 | 292,929.85 | - | -1,439.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,439.00 |
| Dec 31, 2025 | -815.00 |
| Sep 30, 2025 | -21,355.00 |
| Jun 30, 2025 | -26,712.00 |
| Mar 31, 2025 | -46,213.00 |
| Dec 31, 2024 | -57,368.00 |
| Sep 30, 2024 | -62,282.00 |
| Jun 30, 2024 | -80,316.00 |
| Mar 31, 2024 | -129,323.00 |
| Dec 31, 2023 | -166,859.00 |
| Jun 30, 2023 | -240,747.00 |
| Dec 31, 2022 | -270,030.00 |
| Jun 30, 2022 | -311,197.00 |
| Dec 31, 2021 | -377,520.00 |
| Sep 30, 2021 | -456,358.00 |
| Jun 30, 2021 | -528,930.00 |
| Mar 31, 2021 | -316,722.00 |
| Dec 31, 2020 | -112,953.00 |
| Sep 30, 2020 | -178,632.00 |
| Jun 30, 2020 | -228,518.00 |